Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × Lapatinib × Clear all

NCT00096447 2019-07-24

Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

31 enrolled 13 charts

Endometrial Neoplasms